Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 6/20 | 0.83 |
| ▸ | DRD2 | P14416 | 4/20 | 0.83 |
| ▸ | HTR2A | P28223 | 4/20 | 0.83 |
| ▸ | HTR7 | P34969 | 4/20 | 0.83 |
| ▸ | DRD3 | P35462 | 4/20 | 0.83 |
| ▸ | DRD4 | P21917 | 4/20 | 0.83 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.66 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.66 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.66 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.63 |
| ▸ | DRD1 | P21728 | 1/20 | 0.63 |
| ▸ | DRD5 | P21918 | 1/20 | 0.63 |
| ▸ | HRH1 | P35367 | 1/20 | 0.63 |
| ▸ | HTR2C | P28335 | 2/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27237006 | 0.91 | HTR1A (1.00) | HTR1ADRD2HTR2AHTR7DRD3 | |
| SCHEMBL4700352 | 0.83 | ADRA1D (0.63) | HTR1ADRD2HTR2AHTR7DRD3 | |
| SCHEMBL13711971 | 0.82 | KCNH2 (0.71) | HTR1ADRD2HTR2AHTR7DRD3 | |
| SCHEMBL15961309 | 0.80 | POLB (1.00) | HTR1ADRD2HTR2AHTR7DRD3 | |
| SCHEMBL1307947 | 0.79 | KCNH2 (0.64) | HTR1ADRD2HTR2AHTR7DRD3 | |
| SCHEMBL15961344 | 0.79 | POLB (0.92) | HTR1ADRD2HTR2AHTR7DRD3 | |
| SCHEMBL9045494 | 0.78 | DRD2 (0.60) | HTR1ADRD2HTR2AHTR7DRD3 | |
| Hydrochloric Acid SCHEMBL2516709 | 0.78 | KCNH2 (0.62) | HTR1ADRD2HTR2AHTR7DRD3 | |
| SCHEMBL10725629 | 0.78 | HTR1A (0.78) | HTR1ADRD2HTR2AADRA1DADRA1A | |
| SCHEMBL27236997 | 0.77 | DRD3 (1.00) | HTR1ADRD2HTR2AHTR7DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8629147-B2 | Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders | CHEMBRIDGE CORPORATION (US) | 2014-01-14 | — | — | US | disclosed |
| EP-2298770-A1 | Heterocyclic compounds as TrkA modulators | ChemBridge Corporation (US) | 2011-03-23 | — | — | EP | disclosed |
| US-20080207635-A1 | Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders | CHEMBRIDGE CORPORATION | 2008-08-28 | — | — | US | disclosed |
| EP-1960382-A1 | HETEROCYCLIC COMPOUNDS AS TYROSINE KINASE MODULATORS | ChemBridge Research Laboratories, Inc. (US) | 2008-08-27 | — | — | EP | disclosed |
| WO-2007056155-A1 | HETEROCYCLIC COMPOUNDS AS TYROSINE KINASE MODULATORS | CHEMBRIDGE RESEARCH LABORATORIES, INC. (US) | 2007-05-18 | — | — | WO | disclosed |
| US-4038279-A | CNS DEPRESSANTS, ADRENOLYTIC, ANTIPHLOGISTIC, ANALGESIC | BOEHRINGER INGELHEIM GMBH (DT) | 1977-07-26 | — | — | US | disclosed |
| US-4000274-A | PHARMACEUTICAL COMPOSITIONS CONTAINING AN N-ARYL-N'-(PHENYL-OR-PHENOXY-ALKYL)-PIPERAZINE AND METHOD OF USE | BOEHRINGER INGELHEIM GMBH (DT) | 1976-12-28 | — | — | US | disclosed |
| US-3975525-A | CNS DEPRESSANT, NEUROLEPTIC, ANTICHOLESTEROL | BOEHRINGER INGELHEIM GMBH (DT) | 1976-08-17 | — | — | US | disclosed |
| US-3941789-A | CNS DEPRESSANT, ADRENOLYTIC, ANTIPHLOGISTIC, ANALGESIC, ANTIHISTAMINE, ANTICHOLESTEROL | BOEHRINGER INGELHEIM GMBH (DT) | 1976-03-02 | — | — | US | disclosed |
| US-3937708-A | CNS-DEPRESSANTS, NEUROLEPTICS, ANALGESICS, ANTIPHLOGISTICS, SPASMOLYTICS, BRONCHOLYTICS, HYPOTENSIVES, ANTICHOLESTEREMICS | BOEHRINGER INGELHEIM GMBH (DT) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207635-A1 | Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders | LCK, MALT1, MYD88 | HTR1A 3574/4885DRD2 4385/4885HTR2A 3408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.